Zeria Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zeria Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
CMIC Holdings Co Ltd
sales of 69.87 billion Japanese Yen [US$616.24 million]
Aska Pharmaceutical Company Limited
(48.94 billion Japanese Yen [US$431.69 million]
of which 90%
was Pharmaceutical Products Business), and
Fuso Pharmaceutical Industries Ltd
(45.90 billion Japanese Yen [US$404.84 million]
of which 100%
was Pharmaceutical Business).
Zeria Pharmaceutical Co Ltd reported sales of ¥64.57 billion (US$569.50 million)
March of 2018.
decrease of 0.4%
versus 2017, when the company's sales were ¥64.85 billion.
Contributing to the drop in overall sales was the 1.5% decline
in Consumer Healthcare Business, from ¥30.28 billion to ¥29.83 billion.
However, these declines were partially offset by the increase in sales of
Pharmaceuticals Business (up 0.4% to ¥34.58 billion)
Other (up 8.5% to ¥154.17 million)